Skip Ribbon Commands
Skip to main content

News Release


AstraZeneca appoints Jones Lang LaSalle as Global Real Estate Advisory supplier

London, 14th April 2009 – Global pharmaceutical company AstraZeneca has recently appointed Jones Lang LaSalle (JLL) as its Global Real Estate Advisory supplier. The appointment follows a global sourcing programme conducted by AstraZeneca’s Strategic Real Estate Team.

AstraZeneca expects to work exclusively with Jones Lang LaSalle at a Strategic Real Estate level and as preferred supplier at a local transactions level.  Paul Youds, Head of UK Strategic Real Estate explains, “This arrangement will provide an essential external capability for us to drive additional value from our global asset base. Jones Lang LaSalle has demonstrated a clear capability and global reach to help further develop our Real Estate strategy and deliver real value to our bottom line. We very much see Jones Lang LaSalle as a fully integrated part of our Real Estate Team going forward.”

Robert Bonwell, Head of Corporate Solutions at Jones Lang LaSalle adds; “Our clients have a variety of models and we have demonstrated our agility to provide a global strategy and account team for this unique opportunity, whilst enabling the use of best in class at a local transactions level. We are very excited at the opportunity of developing a long term strategic relationship with AstraZeneca to jointly deliver increased value from their real estate portfolio.”